Glitazones discontinued in certain countries due to an unfavorable risk/benefit ratio

Last update : 25/09/2012
II - Pulmonary edema - Acute lung injury - ARDS
V - Pleural and/or pericardial involvement
X - Systemic/Distant conditions, syndromes and reactions
XII - Cardiovascular involvement / toxicity